Susheela Carroll
About Susheela Carroll
Susheela Carroll is the Director of Clinical Science at Calithera Biosciences, where she has worked since 2019. She has a diverse background in clinical science and research, with previous roles at Genentech and academic institutions.
Work at Calithera Biosciences
Susheela Carroll has been serving as the Director of Clinical Science at Calithera Biosciences since 2019. In this role, she oversees clinical development strategies and ensures the successful execution of clinical trials. Her responsibilities include collaborating with cross-functional teams to advance the company's drug development pipeline. Carroll's expertise in clinical science contributes to the organization's focus on innovative therapies for cancer and other serious diseases.
Previous Experience at Genentech
Carroll held multiple positions at Genentech, where she gained extensive experience in clinical science and competitive intelligence. She worked as a Clinical Scientist Associate from 2015 to 2018, focusing on clinical trial design and execution. Prior to that, she served as a Global Competitive Intelligence Manager from 2014 to 2015, where she analyzed market trends and competitive landscapes. Additionally, she was a Clinical Scientist from 2018 to 2019 and a Postdoctoral Fellow from 2011 to 2012, contributing to various research initiatives.
Education and Expertise
Susheela Carroll earned her Ph.D. in Molecular and Cell Biology from the University of California, Berkeley, completing her studies from 2005 to 2010. She also holds a B.S. in Molecular and Cellular Biology from the University of Arizona, where she studied from 2001 to 2005. Her academic background provides a strong foundation in biological sciences, which supports her work in clinical research and development.
Research Experience
Carroll has a diverse research background, having worked as a Graduate Student at UC Berkeley from 2005 to 2010. During her undergraduate studies at the University of Arizona, she served as a Student Researcher from 2003 to 2005. Additionally, she was a BRAVO Student Researcher at Queen's University Belfast in 2004 for two months. These experiences contributed to her understanding of scientific research methodologies and clinical applications.